Racial variation in dosage requirements of tacrolimus

被引：67
作者：
Andrews, PA
Sen, M
Chang, RWS
机构：
来源：
LANCET | 1996年 / 348卷 / 9039期
关键词：
D O I：
10.1016/S0140-6736(04)70087-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1446 / 1446
页数：1
相关论文
共 5 条
[1]   GEOGRAPHICAL INTERRACIAL DIFFERENCES IN POLYMORPHIC DRUG OXIDATION - CURRENT STATE OF KNOWLEDGE OF CYTOCHROMES P450 (CYP) 2D6 AND 2C19 [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1995, 29 (03) :192-209
[2]  
GRENIER FC, 1991, TRANSPLANT P, V23, P2748
[3]   EVIDENCE OF TOXIC METABOLITE STRESS IN BLACK SOUTH-AFRICANS WITH CHRONIC-PANCREATITIS [J].
GUT, A ;
CHALONER, C ;
SCHOFIELD, D ;
SANDLE, LR ;
PURMASIR, M ;
SEGAL, I ;
BRAGANZA, JM .
CLINICA CHIMICA ACTA, 1995, 236 (02) :145-153
[4]   INFLUENCE OF CYCLOSPORINE PHARMACOKINETICS, TROUGH CONCENTRATIONS, AND AUC MONITORING ON OUTCOME AFTER KIDNEY-TRANSPLANTATION [J].
LINDHOLM, A ;
KAHAN, BD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (02) :205-218
[5]  
SCHROEDER TJ, 1995, TRANSPLANT P, V27, P837
1